PP
ELV icon

PFS Partners’s Elevance Health ELV Stock Holding History

PFS Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.13K Hold
13
– – ﹤0.01% 453
2026
Q1 		$3.87K Hold
13
– – ﹤0.01% 454
2025
Q4 		$4.61K Hold
13
– – ﹤0.01% 435
2025
Q3 		$4.22K Hold
13
– – ﹤0.01% 440
2025
Q2 		$5.06K Buy
+13
New +$5.23K ﹤0.01% 394
2024
Q3 		– Sell
-25
Closed -$13.7K – 455
2024
Q2 		$13.7K Hold
25
– – 0.01% 235
2024
Q1 		$13.1K Hold
25
– – 0.01% 246
2023
Q4 		$11.9K Hold
25
– – 0.01% 252
2023
Q3 		$10.9K Hold
25
– – 0.01% 235
2023
Q2 		$11.1K Buy
+25
New +$11.5K 0.01% 256

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

PFS Partners's ELV Position: Q2 2026 in Review

PFS Partners held its Elevance Health (ELV) position steady in Q2 2026 at 13 shares worth $5.13K. The position accounts for ﹤0.01% of the portfolio, ranked #453.

PFS Partners first reported a position in ELV in Q2 2023 and has held it in 10 quarters since. The position peaked at $13.7K in Q2 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • PFS Partners held 13 shares of Elevance Health worth $5.13K as of Q2 2026.
  • PFS Partners left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up ﹤0.01% of PFS Partners's portfolio in Q2 2026, its #453 holding.
  • PFS Partners first reported a position in Elevance Health in Q2 2023 and has held it in 10 quarters since.
  • PFS Partners's Elevance Health position peaked at $13.7K in Q2 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on PFS Partners's 13F filing for Q2 2026, filed 20 Jul 2026.